Cargando…

Association of multiparametric MRI quantitative imaging features with prostate cancer gene expression in MRI-targeted prostate biopsies

Standard clinicopathological variables are inadequate for optimal management of prostate cancer patients. While genomic classifiers have improved patient risk classification, the multifocality and heterogeneity of prostate cancer can confound pre-treatment assessment. The objective was to investigat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stoyanova, Radka, Pollack, Alan, Takhar, Mandeep, Lynne, Charles, Parra, Nestor, Lam, Lucia L.C., Alshalalfa, Mohammed, Buerki, Christine, Castillo, Rosa, Jorda, Merce, Ashab, Hussam Al-deen, Kryvenko, Oleksandr N., Punnen, Sanoj, Parekh, Dipen J., Abramowitz, Matthew C., Gillies, Robert J., Davicioni, Elai, Erho, Nicholas, Ishkanian, Adrian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288193/ https://www.ncbi.nlm.nih.gov/pubmed/27438142 http://dx.doi.org/10.18632/oncotarget.10523

Ejemplares similares

Clinical-Genomic Risk Group Classification of Suspicious Lesions on Prostate Multiparametric-MRI
por: Stoyanova, Radka, et al.
Publicado: (2023)

Multiparametric-MRI and Targeted Biopsies in the Management of Prostate Cancer Patients on Active Surveillance
por: Sandler, Kiri, et al.
Publicado: (2015)

Automatic Detection and Quantitative DCE-MRI Scoring of Prostate Cancer Aggressiveness
por: Parra, Nestor Andres, et al.
Publicado: (2017)

Automatic Detection of Prostate Tumor Habitats using Diffusion MRI
por: Tschudi, Yohann, et al.
Publicado: (2018)

Longitudinal Changes and Predictive Value of Multiparametric MRI Features for Prostate Cancer Patients Treated with MRI-Guided Lattice Extreme Ablative Dose (LEAD) Boost Radiotherapy
por: Algohary, Ahmad, et al.
Publicado: (2022)

Evolving transcriptomic fingerprint based on genome‐wide data as prognostic tools in prostate cancer
por: Alshalalfa, Mohammed, et al.
Publicado: (2015)

Gene expression signatures of neuroendocrine prostate cancer and primary small cell prostatic carcinoma
por: Tsai, Harrison K., et al.
Publicado: (2017)

Optimizing patient's selection for prostate biopsy: A single institution experience with multi-parametric MRI and the 4Kscore test for the detection of aggressive prostate cancer
por: Punnen, Sanoj, et al.
Publicado: (2018)

Transcriptome-Wide Detection of Differentially Expressed Coding and Non-Coding Transcripts and Their Clinical Significance in Prostate Cancer
por: Erho, Nicholas, et al.
Publicado: (2012)

Malakoplakia of the prostate diagnosed on multiparametric-MRI ultrasound fusion guided biopsy: A case report and review of the literature
por: Velasquez, Maria C., et al.
Publicado: (2017)

Predicting clinically significant prostate cancer using DCE-MRI habitat descriptors
por: Parra, Andres N., et al.
Publicado: (2018)

Entering an era of radiogenomics in prostate cancer risk stratification
por: Soodana-Prakash, Nachiketh, et al.
Publicado: (2018)

Erratum: Predicting clinically significant prostate cancer using DCE-MRI habitat descriptors
por: Parra, N. Andres, et al.
Publicado: (2019)

Development of a predictive model for stromal content in prostate cancer samples to improve signature performance
por: Boufaied, Nadia, et al.
Publicado: (2019)

Genomic “Dark Matter” in Prostate Cancer: Exploring the Clinical Utility of ncRNA as Biomarkers
por: Vergara, Ismael A., et al.
Publicado: (2012)

Characterization of transcriptomic signature of primary prostate cancer analogous to prostatic small cell neuroendocrine carcinoma
por: Alshalalfa, Mohammed, et al.
Publicado: (2019)

Magnetic resonance imaging (MRI)-based radiomics for prostate cancer radiotherapy
por: Yang, Fei, et al.
Publicado: (2018)

Impact of the SPOP Mutant Subtype on the Interpretation of Clinical Parameters in Prostate Cancer
por: Liu, Deli, et al.
Publicado: (2018)

A 4K score/MRI‐based nomogram for predicting prostate cancer, clinically significant prostate cancer, and unfavorable prostate cancer
por: Wagaskar, Vinayak G., et al.
Publicado: (2021)

Classifying Malignancy in Prostate Glandular Structures from Biopsy Scans with Deep Learning
por: Fogarty, Ryan, et al.
Publicado: (2023)

Distinct transcriptional repertoire of the androgen receptor in ETS fusion-negative prostate cancer
por: Berglund, Anders E., et al.
Publicado: (2018)

Contemporary role of postoperative radiotherapy for prostate cancer
por: Dal Pra, Alan, et al.
Publicado: (2018)

Potential Impact on Clinical Decision Making via a Genome-Wide Expression Profiling: A Case Report
por: Kim, Hyun, et al.
Publicado: (2016)

Prostatic Leiomyoma – Multiparametric Prostate MRI Features
por: Vergauwen, Ortwin, et al.
Publicado: (2018)

Multiparametric MRI in Prostate Cancer
por: Esen, Tarık, et al.
Publicado: (2014)

Genomic and epigenomic analysis of high-risk prostate cancer reveals changes in hydroxymethylation and TET1
por: Spans, Lien, et al.
Publicado: (2016)

Generative Adversarial Networks Can Create High Quality Artificial Prostate Cancer Magnetic Resonance Images
por: Xu, Isaac R. L., et al.
Publicado: (2023)

Divorcing Diagnosis From Treatment: Contemporary Management of Low-Risk Prostate Cancer
por: Glass, Allison S., et al.
Publicado: (2013)

The long noncoding RNA landscape of neuroendocrine prostate cancer and its clinical implications
por: Ramnarine, Varune Rohan, et al.
Publicado: (2018)

Multiparametric-MRI in diagnosis of prostate cancer
por: Ghai, Sangeet, et al.
Publicado: (2015)

A Quality Control System for Automated Prostate Segmentation on T2-Weighted MRI
por: Sunoqrot, Mohammed R. S., et al.
Publicado: (2020)

Discovery and Validation of Novel Expression Signature for Postcystectomy Recurrence in High-Risk Bladder Cancer
por: Mitra, Anirban P., et al.
Publicado: (2014)

Ethnic heterogeneity and prostate cancer mortality in Hispanic/Latino men: a population-based study
por: Chinea, Felix M., et al.
Publicado: (2017)

Impact of Meat Consumption, Preparation, and Mutagens on Aggressive Prostate Cancer
por: Punnen, Sanoj, et al.
Publicado: (2011)

Could Biparametric MRI Replace Multiparametric MRI in the Management of Prostate Cancer?
por: Iacob, Roxana, et al.
Publicado: (2023)

Integrating multiparametric prostate MRI into clinical practice
por: Padhani, A.R.
Publicado: (2011)

Multiparametric MRI of the prostate: the hope for the urology community
por: Kozikowski, Mieszko, et al.
Publicado: (2016)

Repeatability of Multiparametric Prostate MRI Radiomics Features
por: Schwier, Michael, et al.
Publicado: (2019)

Effect of a genomic classifier test on clinical practice decisions for patients with high-risk prostate cancer after surgery
por: Badani, Ketan K, et al.
Publicado: (2015)

Imaging for the selection and monitoring of men on active surveillance for prostate cancer
por: Velasquez, Maria C., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_l98hbl4lrqf8cci1sal4u9gud8